Marie-Therese
Marie-Therese Charreyre, Mornant FR
Patent application number | Description | Published |
---|---|---|
20080290321 | Fluorescent Polymers Soluble in an Aqueous Solution and a Method for the Production Thereof - The invention relates to fluorescent polymers soluble in an aqueous solution carrying at least 5 fluorophores which are distributed on the polymer and which exhibit the following properties: | 11-27-2008 |
Marie-Therese Nortier, Milly S/therain FR
Patent application number | Description | Published |
---|---|---|
20090263547 | ASSEMBLY FOR FOOD PRODUCT AND METHOD FOR HEATING SAID ASSEMBLY - The invention relates to a pack for a food product comprising | 10-22-2009 |
Marie-Therese Scheirlinck, Zottegem BE
Patent application number | Description | Published |
---|---|---|
20100235947 | Rice Pollen-Preferential Promoters And Uses Thereof - The present invention relates to rice genomic promoter sequences which promote transcription preferentially in microspores and/or pollen of plants. Also provided are chimeric genes comprising these promoter sequences, and plant transformation vectors comprising these chimeric genes. The present invention also discloses plant cells, plant tissues, plants, seeds and grains comprising these chimeric genes. The invention further discloses methods for expressing foreign nucleic acid sequences preferentially in pollen and for producing plants with modified pollen fertility. | 09-16-2010 |
20140359901 | SEED-SPECIFIC PROMOTER IN COTTON - The present application discloses a(n) (isolated) nucleic acid sequence comprising a nucleotide sequence selected from (a) SEQ ID NO: 1 or a fragment thereof, wherein said fragment comprises at least 400 consecutive nucleotides of SEQ ID NO: 1 and has seed-specific promoter activity; (b) a nucleotide sequence with at least 80% sequence identity with SEQ ID NO: 1 and having seed-specific promoter activity; (c) a nucleotide sequence hybridizing under stringent conditions to the nucleotide sequence of (a) or (b); and (d) a nucleotide sequence complementary to the nucleotide sequence of any one of (a) to (c). Further disclosed herein is a chimeric gene comprising the (isolated) nucleic acid described herein operably linked to a nucleic acid coding for an expression product of interest, and optionally a transcription termination and polyadenylation sequence. Also disclosed herein are a vector, a transgenic plant cell, a transgenic plant and a seed as characterized in the claims. Methods disclosed herein relate to the production of a transgenic plant, growing cotton, producing a seed, effecting seed-specific expression of a product in cotton and of altering fiber properties in a cotton plant as characterized in the claims. | 12-04-2014 |
Marie-Thérèse Dimanche-Boitrel, Melesse FR
Patent application number | Description | Published |
---|---|---|
20130108584 | RECOMBINANT VECTOR FOR PRODUCING AND SECRETING AMINO ACID SEQUENCES OF INTEREST BY PROPIONIBACTERIA AND APPLICATIONS THEREOF | 05-02-2013 |
20140154213 | RECOMBINANT VECTOR FOR PRODUCING AND SECRETING PEPTIDE OR PROTEIN OF INTEREST BY PROPIONIBACTERIA AND APPLICATIONS THEREOF - The present invention relates to a recombinant vector for expressing and secreting, by a | 06-05-2014 |
Marie-Thérèse Giudici-Orticoni, Marseille FR
Patent application number | Description | Published |
---|---|---|
20120305476 | TREATMENT METHOD FOR REDUCING THE PRODUCTION OF AN H2S COMPOUND IN AQUEOUS EFFLUENTS PASSING INTO A PIPE - A treatment method for reducing or preventing the production of sulfide compounds of hydrogen such as H | 12-06-2012 |
Marie-Thérèse Giudici-Orticoni, Marseille FR
Patent application number | Description | Published |
---|---|---|
20120305476 | TREATMENT METHOD FOR REDUCING THE PRODUCTION OF AN H2S COMPOUND IN AQUEOUS EFFLUENTS PASSING INTO A PIPE - A treatment method for reducing or preventing the production of sulfide compounds of hydrogen such as H | 12-06-2012 |
Marie-Thérèse Le Dall, Genevilliers FR
Patent application number | Description | Published |
---|---|---|
20100041115 | PRODUCTION OF DICARBOXYLIC ACIDS BY IMPROVED MUTANT STRAINS OF YARROWIA LIPOLYTICA - The invention concerns a method for producing dicarboxylic acids (DCA) with long hydrocarbon chains, also called diacids, which consists in culturing a mutant strain of | 02-18-2010 |
Marie-Thérèse Le Dall, Genevilliers FR
Patent application number | Description | Published |
---|---|---|
20100041115 | PRODUCTION OF DICARBOXYLIC ACIDS BY IMPROVED MUTANT STRAINS OF YARROWIA LIPOLYTICA - The invention concerns a method for producing dicarboxylic acids (DCA) with long hydrocarbon chains, also called diacids, which consists in culturing a mutant strain of | 02-18-2010 |
Marie-Thérèse Paternostre, Verrieres Le Buisson FR
Patent application number | Description | Published |
---|---|---|
20110178013 | NOVEL OCTAPEPTIDE COMPOUNDS DERIVED FROM SOMATOSTATIN AND THE THERAPEUTIC USE THEREOF - The present invention relates to novel octapeptide compounds of general formula (I): H-2-Nal | 07-21-2011 |
20130252892 | NOVEL OCTAPEPTIDE COMPOUNDS AND THERAPEUTIC USE THEREOF - The present invention relates to novel octapeptide compounds of general formula (I), | 09-26-2013 |
Marie-Thérèse Paternostre, Verrieres Le Buisson FR
Patent application number | Description | Published |
---|---|---|
20130252892 | NOVEL OCTAPEPTIDE COMPOUNDS AND THERAPEUTIC USE THEREOF - The present invention relates to novel octapeptide compounds of general formula (I), | 09-26-2013 |
Marie-Thérèse Simon-Gage-Soufflot, Chaville FR
Patent application number | Description | Published |
---|---|---|
20110144036 | HIP/PAP Polypeptide Composition for Use in Liver Regeneration and for the Prevention of Liver Failure - This invention is based on the experimental finding that HIP/PAP has mitogenic and antiapoptotic effects in vitro on hepatocytes in primary culture. Moreover, HIP/PAP is a mitogenic and anti-apoptotic molecule for hepatocytcs, in vivo, during liver failure and liver regeneration. The present invention is also based on the experimental finding that HIP/PAP administration has no adverse effects in mammals. This invention concerns a pharmaceutical composition for stimulating liver regeneration in vivo including after chronic/acute liver failure, comprising an effective amount of a polypeptide comprising an amino acid sequence having 90% amino acid identity with the polypeptide consisting of the amino acid sequence starting at the amino acid residue (36) and ending at the amino acid residue (175) of sequence SEQ ID No 1, in combination with at least one physiologically acceptable excipient. | 06-16-2011 |